Category Archives: Byetta Cancer

Featured Stories

Study Finds Plavix May Only Benefit Smokers

An emerging study finds that blood thinner Plavix may only benefit smokers. Plavix (clopidogrel) is prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, including the heart attacks and strokes it is supposed to prevent, gastrointestinal and cerebral bleeding, bleeding ulcers, ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Soda Consumption Causes Early Puberty & Girls’ Cancer Risk

Soda Consumption Causes Early Puberty and Increases Girls’ Cancer Risk

Drinking just one-and-a-half cans of sugar-sweetened soda a day can bring on early puberty in girls and increase their breast cancer risk.

Read More

Knee Replacement Patients Should Consider Nickel Allergies before Surgery

Individuals considering undergoing knee replacement surgery should ask their doctors to run a test to determine if they have a nickel allergy. Determining if a patient suffers from a nickel allergy will ensure the right knee implant is chosen for their surgery, and possibly save them from considerable pain and ...

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Image Source: saidaonline.com

Sleep Aids Can Increase Alzheimer’s Risk

A new study has found that over-the-counter sleeping aids and anti-allergy medicines can increase the risk of Alzheimer’s disease.

Read More

Oklahoma Woman Latest to Head to Court Over Alleged DePuy ASR Hip Implant Injuries

Lawsuits filed by alleged victims of DePuy Orthopaedics’ recalled ASR hip replacement devices continue to pile up in the multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio. Most recently, a woman from Pryor, Oklahoma, filed suit alleging complications caused by a DePuy ASR hip implant ...

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Failing DePuy ASR Hip Implants Sending Hundreds of Australians Back to the OR

Roughly 1,000 people in Australia have had to undergo revision surgeries because of failed DePuy ASR hip implants. According to TheAge.com, DePuy Orthopaedics has heard from more than 4,000 people in Australia and New Zealand seeking help with the recalled metal-on-metal hip replacement devices.

Read More

Medtronic Sprint Fidelis Leads Vulnerable to Fracture after ICD Switch

Medtronic Sprint Fidelis leads are vulnerable to fracture following ICD switch, says a new study published in the June issue of the journal Heart Rhythm.

Read More

Study: Type 2 Diabetes Drugs May Lead to Pancreatic Damage

A recent study found that Type 2 diabetics taking drugs such as Januvia and Byetta, might be at increased risk for pancreatic damage, including pancreatic cell growth that could lead to cancer. The study, out of the University of California, … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Some Type 2 Diabetes Drugs Associated with Pancreatitis, Pancreatic Cancer

Some Type 2 diabetes drugs are being associated with potential increased risks for pancreatitis and pancreatic cancer. The drugs, known as incretin mimetic drugs include drugs such as  Byetta and Bydureon (exenatide); Victoza (liraglutide); Januvia, Janumet, Janumet XR, and Juvisync … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

FDA Evaluating Cancer Risks in Type 2 Diabetes Drugs

In a just-released U.S. Food and Drug Administration (FDA) Drug Safety Communication, the agency said it is investigating reports of possible increased risk of pancreatitis and pre-cancerous findings in some Type 2 diabetes drugs. Incretin mimetic drugs imitate the body’s … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

JAMA Study: Januvia, Byetta Double Risks for Pancreatitis

Prior research revealed that Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Now, a new study finds that the drugs may double … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Januvia, Byetta Linked to Adverse Health Events

Januvia (sitagliptin) and Byetta (exenatide), prescribed for the treatment of Type 2 diabetes, have been associated with reports of increased risks for pancreatic and thyroid cancers. Researchers at the University of California, Los Angeles looked at the both Januvia and … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Amylin Hid Byetta Study Showing Association with Heart Side Effects, FDA Says

Amylin Pharmaceuticals, the maker of Byetta, is coming under fire for allegedly hiding a study that revealed serious heart risks associated with the type 2 diabetes medication.  According to a report from TheStreet.com, the U.S. Food & Drug Administration (FDA) … Continue reading

Posted in Byetta Cancer, Pharmaceuticals | Tagged |

Pancreas Worries Have Some Docs Backing Away From Byetta, Januvia

A new study indicates that some doctors are becoming wary of Januvia (sitagliptin) and Byetta (exenatide), after research linked the type 2 diabetes drugs to an increased risk of pancreatitis and pancreatic cancer. The survey, conducted by DTW Research, found … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza Raises Thyroid Tumor, Pancreatitis Fears

The maker of < "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza (liraglutide) is reminding doctors of some serious side effects that may be associated with the Type II Diabetes drug – thyroid C-cell tumors and acute pancreatitis. Novo Nordisk decided to issue a “Dear Healthcare Provider” … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

Victoza, Similar Diabetes Drugs Raise Safety Concerns

< "http://www.yourlawyer.com/practice_areas/defective_drugs">Victoza, a Type 2 Diabetes drug approved just last year, is raising concerns about pancreatitis. According to the Institute for Safe Medication Practices’ (ISMP) latest “QuarterWatch” report, Victoza has been associated with a growing number of pancreatitis cases since … Continue reading

Posted in Byetta Cancer |

Amylin Wins Temporary Restraining Order in Byetta Spat

Amylin Pharmaceuticals has scored a victory in its quest to prevent Eli Lilly from using its Byetta sales force from marketing a competing drug. < "http://www.yourlawyer.com/topics/overview/Byetta-Side-Effects-Pancreatic-Liver-Thyroid-Cancer-Lawsuit">Byetta, which is treats Type II diabetes, is marketed jointly by Eli Lilly and Amylin. … Continue reading

Posted in Byetta Cancer, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.